Jiří Pavlů

2.9k total citations
62 papers, 1.6k citations indexed

About

Jiří Pavlů is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Jiří Pavlů has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Hematology, 17 papers in Oncology and 13 papers in Genetics. Recurrent topics in Jiří Pavlů's work include Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Jiří Pavlů is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Chronic Myeloid Leukemia Treatments (15 papers). Jiří Pavlů collaborates with scholars based in United Kingdom, Germany and France. Jiří Pavlů's co-authors include Jane F. Apperley, Dragana Milojković, David Marín, John M. Goldman, Catherine Garnett, Richard Szydlo, Katayoun Rezvani, Letizia Foroni, Alistair Reid and Marco Bua and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jiří Pavlů

58 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiří Pavlů United Kingdom 19 1.1k 649 429 400 379 62 1.6k
Edward Kanfer United Kingdom 26 1.1k 1.0× 394 0.6× 477 1.1× 163 0.4× 416 1.1× 55 1.8k
Emilio Paolo Alessandrino Italy 22 1.1k 1.0× 506 0.8× 305 0.7× 87 0.2× 179 0.5× 60 1.7k
Nadežda Basara Germany 23 1.4k 1.2× 312 0.5× 520 1.2× 86 0.2× 420 1.1× 70 2.1k
Alida Dominietto Italy 26 1.9k 1.7× 379 0.6× 797 1.9× 87 0.2× 685 1.8× 77 2.4k
Flore Sicre de Fontbrune France 22 837 0.8× 426 0.7× 192 0.4× 77 0.2× 861 2.3× 107 1.9k
Anna Paola Iori Italy 20 1.1k 1.0× 300 0.5× 276 0.6× 71 0.2× 298 0.8× 65 1.5k
Woo-Sung Min South Korea 21 1.2k 1.0× 221 0.3× 435 1.0× 77 0.2× 454 1.2× 131 1.7k
Ira Braunschweig United States 19 1.4k 1.2× 283 0.4× 642 1.5× 67 0.2× 635 1.7× 76 2.0k
K. B. McCredie United States 22 1.1k 1.0× 439 0.7× 444 1.0× 168 0.4× 191 0.5× 52 1.7k
Francesco Nobile Italy 21 846 0.8× 516 0.8× 221 0.5× 58 0.1× 178 0.5× 74 1.4k

Countries citing papers authored by Jiří Pavlů

Since Specialization
Citations

This map shows the geographic impact of Jiří Pavlů's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Pavlů with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Pavlů more than expected).

Fields of papers citing papers by Jiří Pavlů

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Pavlů. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Pavlů. The network helps show where Jiří Pavlů may publish in the future.

Co-authorship network of co-authors of Jiří Pavlů

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Pavlů. A scholar is included among the top collaborators of Jiří Pavlů based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Pavlů. Jiří Pavlů is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mullish, Benjamin H., Andrew J. Innes, Lauren A. Roberts, et al.. (2024). Intestinal M icrobiota Transplant Prior to A llogeneic S tem Cell T ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trial. BMJ Open. 14(12). e093120–e093120. 1 indexed citations
2.
Loke, Justin, Marlen Metzner, Rebecca H. Boucher, et al.. (2021). Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high‐risk acute myeloid leukaemia ineligible for intensive chemotherapy. British Journal of Haematology. 196(2). 368–373. 3 indexed citations
3.
Innes, Andrew J., Benjamin H. Mullish, Rohma Ghani, et al.. (2021). Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation. Frontiers in Cellular and Infection Microbiology. 11. 684659–684659. 23 indexed citations
4.
Dholaria, Bhagirathbhai, Myriam Labopin, Emanuele Angelucci, et al.. (2020). Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 27(2). 171.e1–171.e8. 8 indexed citations
5.
Tharakan, Tharu, et al.. (2019). BK Virus Associated Haemorrhagic Cystitis. A systematic review of current prevention and treatment strategies. International Journal of Surgery. 63. 34–42. 20 indexed citations
6.
Bassan, Renato, Dieter Hoelzer, Xavier Thomas, et al.. (2019). Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study. Advances in Therapy. 36(4). 870–879. 4 indexed citations
7.
Szydlo, Richard, Mary Hickson, Andrew J. Innes, et al.. (2018). Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies. Clinical Nutrition. 38(2). 738–744. 40 indexed citations
8.
Stringaris, Kate, Takuya Sekine, Ahmed Alsuliman, et al.. (2014). Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia. Haematologica. 99(5). 836–847. 158 indexed citations
9.
Auner, Holger W., Richard Szydlo, Aristeidis Chaidos, et al.. (2013). Salvage autologous stem cell transplantation for multiple myeloma relapsing or progressing after up-front autologous transplantation. Leukemia & lymphoma. 54(10). 2200–2204. 32 indexed citations
10.
Chaidos, Aristeidis, Scott D. Patterson, Richard Szydlo, et al.. (2012). Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation. Blood. 119(21). 5030–5036. 120 indexed citations
11.
Naresh, Kikkeri N., et al.. (2012). Hypoplastic presentation of acute lymphoblastic leukemia. American Journal of Hematology. 87(7). 702–702. 1 indexed citations
12.
Pavlů, Jiří, et al.. (2011). Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome. Leukemia & lymphoma. 52(3). 515–516. 5 indexed citations
13.
Liu, Christine, et al.. (2011). Bone marrow trephine biopsy findings in acute promyelocytic leukemia. American Journal of Hematology. 87(1). 109–110.
14.
Naresh, Kikkeri N. & Jiří Pavlů. (2010). Plasmacytoid dendritic cell nodules in bone marrow biopsies of chronic myelomonocytic leukemia. American Journal of Hematology. 85(11). 893–893. 7 indexed citations
15.
Pavlů, Jiří, Holger W. Auner, Sarah Ellis, et al.. (2010). LACE‐conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B‐cell lymphoma: treatment outcome and risk factor analysis from a single centre. Hematological Oncology. 29(2). 75–80. 7 indexed citations
16.
Pavlů, Jiří, et al.. (2008). Striking bone marrow plasmacytosis in a patient with sickle cell anaemia. British Journal of Haematology. 144(4). 457–457. 1 indexed citations
17.
Pavlů, Jiří, Charles Chuah, Jaspal Kaeda, et al.. (2007). Dual inhibition of ras and bcr‐abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission. British Journal of Haematology. 137(5). 423–428. 8 indexed citations
18.
Pavlů, Jiří, Marie Jackson, & Nicki Panoskaltsis. (2006). GM1‐gangliosidosis type I. British Journal of Haematology. 135(4). 422–422. 1 indexed citations
19.
Pavlů, Jiří, Barbara Czepulkowski, Richard Kaczmarski, & Riaz Jan-Mohamed. (2005). Early blastic transformation with CNS infiltration in a patient with chronic myeloid leukaemia treated with imatinib. The Lancet Oncology. 6(2). 128–128. 8 indexed citations
20.
Pavlů, Jiří, Riaz Jan-Mohamed, & Richard Kaczmarski. (2005). Pathological odontoid fracture. The Lancet Oncology. 7(1). 96–96. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Kanfer Breakdown of academic impact, for papers by Emilio Paolo Alessandrino Breakdown of academic impact, for papers by Nadežda Basara Breakdown of academic impact, for papers by Alida Dominietto Breakdown of academic impact, for papers by Flore Sicre de Fontbrune Breakdown of academic impact, for papers by Anna Paola Iori Breakdown of academic impact, for papers by Woo-Sung Min Breakdown of academic impact, for papers by Ira Braunschweig Breakdown of academic impact, for papers by K. B. McCredie Breakdown of academic impact, for papers by Francesco Nobile
Rankless by CCL
2026